CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 150 enrolled
Drug / intervention
Heparindrug
Likely dose
Heparin 100unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02493504
NCT02493504Phase 4Completed
CompareCT.gov

Effects of Heparin on Early Patency of Arteriovenous Fistula in Angioaccess Surgery of Patients With End-Stage Renal Disease

Fatemeh Hoseinzadegan·interventional·Posted Jul 9, 2015·Updated Jul 9, 2015

In Brief

A Phase 4 clinical trial evaluating Heparin for Arteriovenous Fistula. Completed, enrolled 150 participants.

Detailed Summary

Arteriovenous fistula (AVF) is now the optimal method of obtaining vascular access for dialysis. Measures such as systemic anticoagulation have been proposed as means of increasing patency rates but enough evidence does not exist to support their use. The investigators aimed to evaluate the efficacy of preoperative heparin injection on patency of AVF during the first 24 hours after surgery and to determine whether such measure can be used to prevent early thrombosis of the vascular access.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArteriovenous Fistula
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 9, 2015
Enrollment StartJan 1, 2011
Primary CompletionApr 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.0 years ago

Interventions

Heparindrug

100units/kg of heparin were administered for the case group after dissection prior to anastomosis.